Lynne Sullivan
Director of Finance/CFO at UNITY BIOTECHNOLOGY, INC.
Net worth: 40 906 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ilan Ganot | M | 50 | 11 years | |
| Jonathan Solomon | M | 47 |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 7 years |
| Nathaniel David | M | 56 | 15 years | |
| Adam Koppel | M | 54 | 10 years | |
| Gilmore O’Neill | M | 59 | 20 years | |
| Axel Bolte | M | 52 | 9 years | |
| Robert Woodman | M | 46 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 6 years |
| Jonas Grossman | M | 50 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 5 years |
| Caroline Dorsa | F | 64 | 14 years | |
| Keith Leonard | M | 62 | 8 years | |
| Russell Greig | M | 71 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 5 years |
| Alexander Cumbo | M | 53 | 2 years | |
| Anirvan Ghosh | M | 60 | 7 years | |
| Doug Treco Treco | M | 66 | 4 years | |
| TY Howton | M | 52 | 2 years | |
| Sarah Bhagat | M | 38 | 5 years | |
| William Sibold | M | - |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | - |
| Clare Khan | M | 72 | 3 years | |
| Alexander Nguyen | M | 47 | 3 years | |
| Margo Roberts | M | 69 | 6 years | |
| Michael Hencke | M | - | 12 years | |
| Sukumar Nagendran | M | 58 | 6 years | |
| Annie Ganot | F | - | 11 years | |
| Alan Moses | M | 76 | 4 years | |
| Georgia Keresty | M | 62 | 3 years | |
| Edward Williams | M | 68 | 1 years | |
| Michael Samar | M | 51 | 2 years | |
| Stephen Sherwin | M | 75 | 14 years | |
| Merav Bassan | M | 59 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 5 years |
| Stefan Riley | M | - | - | |
| Nicole Murphy | F | - | 9 years | |
| Ian Smith | M | 58 | 4 years | |
| Glenn F. Pierce | M | 68 |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | 15 years |
| Camille Samuels | F | 52 | 9 years | |
| Ed Mathers Mathers | M | 64 | 7 years | |
| Naomi Zak | M | - |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | - |
| Martin Edwards | M | 68 | 7 years | |
| Martin Freed | M | 63 | 6 years | |
| Reinaldo Diaz | M | 70 | 7 years | |
| Raj Shah | M | 46 | 7 years | |
| Eric Rowinsky | M | 67 | 14 years | |
| Robert Hopfner | M | 51 | 6 years | |
| Wayne I. Lencer | M | - |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | 27 years |
| Adam Stone | M | 44 | 9 years | |
| David Thompson | M | - | 6 years | |
| Paul Berns | M | 57 | 6 years | |
| Przemyslaw Sapieha | M | - | 3 years | |
| Sally McAlister | F | - |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | - |
| Yves Sabbagh | M | - | 4 years | |
| Alison Kessler | F | - | 4 years | |
| Gayle Gironda | F | - | 3 years | |
| Michael Inbar | M | - | 3 years | |
| Jessie Hanrahan | M | 47 | 2 years | |
| Jessica Swann | F | - |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | 15 years |
| Myriam Golembo | M | 59 | 5 years | |
| Sanjay Subramanian | M | 48 | 2 years | |
| Natacha Gassenbach | F | - | 6 years | |
| Eran Elinav | M | - |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 9 years |
| Jake Elkins | M | - | 7 years | |
| Robin Kramer | F | 58 | 6 years | |
| Ginger Gregory | M | 56 | 7 years | |
| Ying Ming Luk | M | - |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | 15 years |
| Matthew Winton | M | 46 | 1 years | |
| Assaf Oron | M | 49 | 5 years | |
| Ruediger Weseloh | M | - | 18 years | |
| Soo-Jin Kim | M | - | 2 years | |
| Kurt C. Gunter | M | 69 | 2 years | |
| Gabriel Brooks | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stephen DiPalma | M | 66 | 2 years | |
| Joel Schneider | M | 39 | 8 years | |
| Stelios Papadopoulos | M | 75 | 15 years | |
| Gregory Covino | M | 59 | 7 years | |
| Joan Mannick | M | 66 | 4 years | |
| William Young | M | 79 | 11 years | |
| James Mullen | M | 65 | 21 years | |
| Matthew Bennett Arnold | M | 55 | 8 years | |
| Michel Vounatsos | M | 62 | 6 years | |
| Rainer Lichtenberger | M | 65 | 14 years | |
| Erez Chimovits | M | 60 | 1 years | |
| Gilad D. Hayeem | M | 57 | 5 years | |
| Paul Clancy | M | 62 | 16 years | |
| Jeffrey Capello | M | 69 | 3 years | |
| Friederike Rotsch | M | 51 | 18 years | |
| David Lacey | M | 71 | 2 years | |
| Jeffrey Chodakewitz | M | 68 | - | |
| Chirfi Guindo | M | 58 | 5 years | |
| Richard Mulligan | M | 69 | 14 years | |
| Robert A. Hamm | M | 72 | 7 years | |
| Eric S. Hoffman | M | 54 | 5 years | |
| John J. McCabe | M | 57 | 3 years | |
| Craig Eric Schneier | M | 76 | 8 years | |
| Paul Sekhri | M | 66 | 2 years | |
| Gbola Amusa | M | 50 | 5 years | |
| Alexander Denner | M | 54 | 14 years | |
| Brian Posner | M | 62 | 14 years | |
| Robert Nelsen | M | 60 | 9 years | |
| Phillip Sharp | M | 79 | 31 years | |
| Graham Cooper | M | 54 | 5 years | |
| Matthew Emmens | M | 72 | 4 years | |
| Karl-Ludwig Kley | M | 72 | 10 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 82 | 82.00% |
| Israel | 14 | 14.00% |
| Germany | 5 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Lynne Sullivan
- Personal Network
